CSIMarket
 


Alaunos Therapeutics Inc   (TCRT)
Other Ticker:  
 

Alaunos Therapeutics Inc 's Leverage Ratio

TCRT's quarterly Leverage Ratio and Total Liabilities, Equity growth




TCRT Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -53.26 % -54.49 % -53.5 % -59.94 % -57.96 %
Y / Y Total Liabilities Change -21.8 % 82.6 % 57.11 % 75.48 % 146.67 %
Leverage Ratio MRQ 1.1 0.84 0.73 0.63 0.66
Overall Ranking # # # # #
Seq. Equity Change -20.08 % -18.2 % -15.39 % -15.5 % -22.17 %
Seq. Total Liabilities Change 4.39 % -5.9 % -2.55 % -18.3 % 143.75 %



Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 4.39%, Leverage Ratio detoriated to 1.1, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Alaunos Therapeutics Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are TCRT Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Alaunos Therapeutics Inc 's Equity $ 32 Millions Visit TCRT's Balance sheet
Alaunos Therapeutics Inc 's Total Liabilities $ 35 Millions Visit TCRT's Balance sheet
Source of TCRT's Sales Visit TCRT's Sales by Geography


Cumulative Alaunos Therapeutics Inc 's Leverage Ratio

TCRT's Leverage Ratio for the trailling 12 Months

TCRT Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -53.26 % -54.49 % -53.5 % -59.94 % -57.96 %
Y / Y Total Liabilities TTM Growth -21.8 % 82.6 % 57.11 % 75.48 % 146.67 %
Leverage Ratio TTM 0.79 0.7 0.52 0.38 0.26
Total Ranking TTM # 1294 # 1394 # 1043 # 768 # 0
Seq. Equity TTM Growth -20.08 % -18.2 % -15.39 % -15.5 % -22.17 %
Seq. Total Liabilities TTM Growth 4.39 % -5.9 % -2.55 % -18.3 % 143.75 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 4.39%, Leverage Ratio improved to 0.79, below Alaunos Therapeutics Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 285 other companies have achieved lower Leverage Ratio than Alaunos Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. 1294.

Explain Leverage Ratio?
Who are TCRT Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 286
Healthcare Sector # 559
Within the Market # 1294


TTM Leverage Ratio Statistics
High Average Low
10.08 0.98 0.11
(Sep 30 2016)   (Jun 30 2020)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Adamis Pharmaceuticals Corp  2.97 $ 8.452  Millions$ 2.845  Millions
Biovie Inc   2.82 $ 16.821  Millions$ 5.961  Millions
Eli Lilly And Company  2.64 $ 26,798.200  Millions$ 10,165.900  Millions
G1 Therapeutics Inc   2.62 $ 120.608  Millions$ 45.965  Millions
Fortress Biotech Inc   2.58 $ 261.890  Millions$ 101.352  Millions
Seres Therapeutics Inc   2.56 $ 172.913  Millions$ 67.585  Millions
Aveo Pharmaceuticals Inc   2.51 $ 72.388  Millions$ 28.845  Millions
Mersana Therapeutics inc   2.49 $ 224.621  Millions$ 90.229  Millions
Ultragenyx Pharmaceutical Inc   2.42 $ 1,134.868  Millions$ 468.829  Millions
Mallinckrodt Plc  2.38 $ 4,408.300  Millions$ 1,849.100  Millions
Jazz Pharmaceuticals Plc  2.37 $ 6,508.768  Millions$ 2,745.194  Millions
Rockwell Medical inc   2.36 $ 38.050  Millions$ 16.136  Millions
Phibro Animal Health Corporation  2.35 $ 616.922  Millions$ 262.756  Millions
Spectrum Pharmaceuticals Inc   2.32 $ 83.077  Millions$ 35.852  Millions
Foghorn Therapeutics Inc   2.27 $ 55.268  Millions$ 24.323  Millions
Palatin Technologies Inc   2.27 $ 19.193  Millions$ 8.449  Millions
Albireo Pharma inc   2.21 $ 221.151  Millions$ 100.071  Millions
Chembio Diagnostics Inc   2.17 $ 38.635  Millions$ 17.793  Millions
Effector Therapeutics Inc   2.17 $ 25.091  Millions$ 11.560  Millions
9 Meters Biopharma Inc   2.13 $ 28.674  Millions$ 13.461  Millions
Maravai Lifesciences Holdings Inc   2.07 $ 1,739.316  Millions$ 841.669  Millions
Ocular Therapeutix Inc   2.04 $ 94.207  Millions$ 46.229  Millions
Bristol myers Squibb Company  2.00 $ 65,525.000  Millions$ 32,734.000  Millions
Clearside Biomedical Inc   1.98 $ 36.732  Millions$ 18.546  Millions
Agile Therapeutics Inc  1.95 $ 12.203  Millions$ 6.260  Millions
Zoetis Inc   1.93 $ 9,011.000  Millions$ 4,662.000  Millions
Plx Pharma Inc   1.91 $ 19.490  Millions$ 10.187  Millions
Landec Corporation  1.85 $ 179.163  Millions$ 96.899  Millions
Apellis Pharmaceuticals Inc   1.84 $ 565.476  Millions$ 307.416  Millions
Aravive Inc   1.81 $ 27.180  Millions$ 15.042  Millions

Date modified: 2022-11-16T22:21:07+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LAZY's Profile

Stock Price

LAZY's Financials

Business Description

Fundamentals

Charts & Quotes

LAZY's News

Suppliers

LAZY's Competitors

Customers & Markets

Economic Indicators

LAZY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071